EPIRUBICIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Epirubicin, and what generic alternatives are available?
Epirubicin is a drug marketed by Actavis Totowa, Cipla Ltd, Ebewe Pharma, Epic Pharma Llc, Fresenius Kabi Usa, Hikma, Hisun Pharm Hangzhou, Hospira, Impax Labs Inc, and Pharmobedient. and is included in fourteen NDAs.
The generic ingredient in EPIRUBICIN is epirubicin hydrochloride. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Epirubicin
A generic version of EPIRUBICIN was approved as epirubicin hydrochloride by HIKMA on June 27th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EPIRUBICIN?
- What are the global sales for EPIRUBICIN?
- What is Average Wholesale Price for EPIRUBICIN?
Summary for EPIRUBICIN
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for EPIRUBICIN |
| DailyMed Link: | EPIRUBICIN at DailyMed |
US Patents and Regulatory Information for EPIRUBICIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | POWDER;INTRAVENOUS | 050807-002 | Sep 15, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 091599-001 | Mar 12, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065371-002 | Nov 28, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
